Fragmento

Heart failure, a final outcome of different cardiomyopathies is currently the most serious problem in the field of cardiology and public health. Despite the extraordinary progress made over the last two decades regarding the understanding of the deeper mechanisms of ventricular failure as an endocrine-metabolic syndrome, it is the major cause of death in the adult population. This justifies the use of polypharmacy with five or more active principles with a view to neutralizing different stages of the adrenergic stimulation cascade. The clinical application of these active principles fascinatesprofessionals, leading them to attach great importance to the heart failure syndrome, so much so that they sometimes accept the etiology of the disease without further questioning and, beyond that, fail to identify causes of heart failure that could be removed. The identification of the causal mechanism of the disease and its removal or neutralization translates into a significant impact on the progression of the disease. This is the case of ischemic myocardiopathies, tachymyopathies, deposit and metabolic diseases and others.

Palabras clave:

2008-09-17   |   1,216 visitas   |   Evalua este artículo 0 valoraciones

Vol. 3 Núm.2. Abril-Junio 2008 Pags. 57-59 Rev Insuf Cardíaca 2008; III(2)